Drug intelligence / Profile preview

recombinant corin

Development stage
Preclinical
Lead developer
Hackensack Meridian Health
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Intravenous, Intraperitoneal
01

Overview

Recombinant corin is a recombinant form of the transmembrane serine protease corin, which plays a vital role in cardiovascular homeostasis by converting pro-atrial natriuretic peptide (pro-ANP) into its active form, atrial natriuretic peptide (ANP). Active ANP promotes natriuresis, diuresis, and vasodilation, thereby regulating blood pressure and preventing cardiac overgrowth. Deficiency in corin activity, often due to genetic variants prevalent in certain populations (e.g., African and Southeast Asian), is linked to salt-sensitive hypertension and heart failure. As a therapeutic candidate, recombinant corin aims to restore natriuretic peptide signaling; preclinical studies have demonstrated its ability to reduce cardiac hypertrophy and improve cardiovascular outcomes in models of hypertension and heart failure.

Other names
Corin replacement therapyrecombinant human corin
02

Targets

NPPA (Atrial natriuretic peptide precursor)

Beyond the preview

Go deeper on recombinant corin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant corin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call